Veeva Systems Inc. $VEEV Shares Sold by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. cut its holdings in Veeva Systems Inc. (NYSE:VEEV) by 89.7% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,469 shares of the technology company’s stock after selling 12,812 shares during the period. Crossmark Global Holdings Inc.’s holdings in Veeva Systems were worth $438,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its position in Veeva Systems by 3.1% during the third quarter. Vanguard Group Inc. now owns 15,429,231 shares of the technology company’s stock worth $4,596,522,000 after acquiring an additional 457,806 shares during the last quarter. Alliancebernstein L.P. grew its position in shares of Veeva Systems by 3.7% in the second quarter. Alliancebernstein L.P. now owns 5,705,648 shares of the technology company’s stock valued at $1,643,113,000 after purchasing an additional 205,997 shares during the last quarter. Principal Financial Group Inc. increased its stake in shares of Veeva Systems by 11.2% during the 3rd quarter. Principal Financial Group Inc. now owns 3,846,877 shares of the technology company’s stock worth $1,146,040,000 after purchasing an additional 388,864 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Veeva Systems by 4.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,476,258 shares of the technology company’s stock worth $1,035,622,000 after purchasing an additional 159,984 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Veeva Systems by 3.8% during the 2nd quarter. Geode Capital Management LLC now owns 3,092,539 shares of the technology company’s stock worth $888,108,000 after purchasing an additional 114,003 shares during the last quarter. 88.20% of the stock is owned by institutional investors and hedge funds.

Veeva Systems Trading Down 1.4%

VEEV stock opened at $186.96 on Thursday. The company has a market cap of $30.73 billion, a PE ratio of 34.56, a price-to-earnings-growth ratio of 1.31 and a beta of 1.09. The stock has a 50-day moving average price of $201.48 and a two-hundred day moving average price of $245.18. Veeva Systems Inc. has a 12-month low of $168.13 and a 12-month high of $310.50.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings data on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $835.95 million for the quarter, compared to the consensus estimate of $810.95 million. Veeva Systems had a return on equity of 14.11% and a net margin of 28.44%.The company’s quarterly revenue was up 16.0% compared to the same quarter last year. During the same period last year, the business posted $1.74 EPS. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. Equities analysts forecast that Veeva Systems Inc. will post 4.35 EPS for the current fiscal year.

Veeva Systems declared that its Board of Directors has approved a share buyback plan on Monday, January 5th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the technology company to reacquire up to 5.5% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s management believes its stock is undervalued.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. Citigroup reduced their target price on Veeva Systems from $319.00 to $291.00 and set a “buy” rating on the stock in a research note on Monday. Morgan Stanley boosted their price target on Veeva Systems from $205.00 to $215.00 and gave the stock an “equal weight” rating in a report on Thursday, March 5th. UBS Group upped their price objective on Veeva Systems from $200.00 to $220.00 and gave the company a “neutral” rating in a research report on Thursday, March 5th. Needham & Company LLC decreased their price objective on Veeva Systems from $355.00 to $270.00 and set a “buy” rating on the stock in a research note on Thursday, March 5th. Finally, Oppenheimer dropped their price objective on Veeva Systems from $325.00 to $275.00 and set an “outperform” rating for the company in a research report on Tuesday, February 24th. Seventeen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $283.70.

Veeva Systems News Roundup

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva acquired AI chat specialist Ostro for roughly $100M to add an AI-driven, compliant brand‑engagement chat tool for patients and HCPs — expands Commercial Cloud capabilities and product moat. Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement
• Positive Sentiment: AOP Health standardized on Veeva’s Industry Cloud across R&D, quality, commercial and data — a notable customer win that supports recurring SaaS revenue and cross‑cloud adoption. AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas
• Positive Sentiment: Q4 results beat expectations with stronger demand for modernization (safety, R&D) and expansion among top 20 pharma customers; management emphasized scalable, automated core systems as the main growth driver. These fundamentals support revenue durability and the long‑term SaaS upsell story. 5 Revealing Analyst Questions From Veeva Systems’s Q4 Earnings Call
• Neutral Sentiment: Analyst/investor attention articles (Zacks, market commentary) highlight interest in Veeva but don’t add new material facts — they may increase trading volume but are unlikely alone to change fundamentals. Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
• Negative Sentiment: Citigroup lowered its expectations/price target for Veeva, signaling analyst concern that recent moves (acquisition spend, guidance cadence) or valuation may not justify current multiples — analyst downgrades can pressure the stock near term. Citigroup Has Lowered Expectations for Veeva Systems (NYSE:VEEV) Stock Price

Insider Buying and Selling

In related news, insider Thomas D. Schwenger sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total value of $231,430.00. Following the transaction, the insider owned 23,204 shares in the company, valued at approximately $5,370,101.72. This trade represents a 4.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 10.30% of the company’s stock.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.